PARKINSON’S DISEASE, AUTOIMMUNITY, AND OLFACTION

REFERENCES

• Abramsky, O., & Litvin, Y. (1978). Autoimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia. Perspectives in Biology and Medicine, 22, 104–114.
   PubMedGoogle Scholar
• Al-Fulaij, M. A., Ren, Y., Beinborn, M., & Kopin, A. S. (2008). Pharmacological analysis of human D1 and D2 dopamine receptor missense variants. Journal of Molecular Neuroscience, 34, 211–223.
   PubMedGoogle Scholar
• Boundy, V. A., Luedtke, R. R., Artymyshyn, R. P., Filtz, T. M., & Molinoff, P. B. (1993). Development of polyclonal anti-D2 dopamine receptor antibodies using sequence-specific peptides. Molecular Pharmacology, 43, 666–676.
   PubMedGoogle Scholar
• Braak, H., & Del Tredici, K. (2009). Neuroanatomy and pathology of sporadic Parkinson's disease. Advances in Anatomy, Embryology and Cell Biology, 201, 1–119.
   PubMed Web of Science ®Google Scholar
• Buck, L., & Axel, R. (1991). A novel multigene family may encode odorant receptors: A molecular basis for odor recognition. Cell, 65, 175–187.
   PubMed Web of Science ®Google Scholar
• Carvey, P. M., McRae, A., Lint, T. F., Ptak, L. R., Lo, E. S., Goetz, C. G., (1991). The potential use of dopamine neuron antibody and a striatal-derived neurotropic factor as diagnostic markers in Parkinson's disease. Neurology, 41, 53–58.
   PubMedGoogle Scholar
• Chazot, P. L., Doherty, A. J., & Stange, P. G. (1993). Antisera specific for D2 dopamine receptors. Biochemical Journal, 289, 789–794.
   PubMedGoogle Scholar
• Chen, S., Le, W. D., Xie, W. J., Alexianu, M. E., Engelhardt, J. I., Siklos, L., (1998). Experimental destruction of substantia nigra initiated by Parkinson disease immunoglobulins. Archives of Neurology, 55, 1075–1080.
   PubMedGoogle Scholar
• Crossman, A. R. (2000). Functional anatomy of movement disorders. Journal of Anatomy, 196, 519–525.
   PubMedGoogle Scholar
• Cztonkwska, A., Jastrzebska, I. K., Cztonkowski, A., Peter, D., & Stefano, G. B. (2002). Immune processes in the pathogenesis of Parkinson's disease—A potential role of microglia and nitric oxide. Medical Science Monitor, 8, 165–177.
   Google Scholar
• Farooqui, S. M., & Prasad, C. (1992). An antibody to dopamine D2 receptor inhibits dopamine antagonist and agonist binding to dopamine D2 receptor cDNA transfected mouse fibroblast cells. Life Science, 51, 1509–1516.
   PubMedGoogle Scholar
• Farooqui, S. M., Brock, J. W., Hamdi, A., & Prasad, C. (1991). Antibodies against synthetic peptides predicted from the nucleotide sequence of D2 receptor recognize native dopamine receptor protein in rat striatum. Journal of Neurochemistry, 57, 1363–1369.
   PubMedGoogle Scholar
• Fiszer, U., Mix, E., Fredrikson, S., Kostulas, V., Olsson, T., & Link, H. (1994). Gamma delta+ T cells are increased in patients with Parkinson's disease. Journal of the Neurological Sciences, 121, 39–45.
   PubMedGoogle Scholar
• He, Y., Le, W. D., & Appel, S. H. (2002). Role of FCγ receptors in nigral cell injury induced by Parkinson's disease immunoglobulin injection into mouse substantia nigra. Experimental Neurology, 176, 322–327.
   PubMed Web of Science ®Google Scholar
• Israel, Z., & Hassin-Bear, S. (2005). Subthalamic stimulation for Parkinson's disease. IMAJ, 7, 458–463.
   Google Scholar
• Jellinger, K. A. (2008). A critical reappraisal of current staging of Lewy-related pathology in human brain. Acta Neuropathologica, 116, 1–16.
   PubMed Web of Science ®Google Scholar
• Johnston, J. M., Wood, D. F., James, J. D., & Johanston, D. G. (1992). Preparation and characterization of an antibody specific to the rat dopamine D2 receptor. Journal of Endocrinology, 134, 227–233.
   PubMedGoogle Scholar
• Katzav, A., Ben-Ziv, T., Chapman, J., Blank, M., Reichlin, M., & Shoenfeld, Y. (2008). Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS-SLE (depression). Journal of Autoimmune, 21, 393–398.
   Google Scholar
• Katzav, A., Solodeev, I., Brodsky, O., Chapman, J., Pick, C. J., Blank, M., (2007). Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system. Arthritis & Rheumatism, 56, 938–948.
   PubMed Web of Science ®Google Scholar
• Kowalski, J., Blada, P., Kucia, K., Madej, A., & Herman, Z. S. (2001). Neuroleptics normalize increased release of interleukin—1 beta and tumor necrosis factor-alpha from monocytes in schizophrenia. Schizophrenia Research, 50, 169–175.
   PubMed Web of Science ®Google Scholar
• Le, W. D., Rowe, D. B., Jankovic, J., Xei, W., & Apple, S. H. (1999). Effects of cerebrospinal fluid from patients with Parkinson disease on dopaminergic cells. Archives of Neurology, 56, 194–200.
   PubMedGoogle Scholar
• Lerler, A., & Bagic, A. (2008). Olfactory pathogenesis of idiopathic Parkinson disease revisited. Movement Disorders, 23, 1076–1084.
   PubMedGoogle Scholar
• Lesage, S., & Brice, A. (2009). Parkinson's disease: From monogenic forms to genetic susceptibility factors. Human Molecular Genetics, 18, 48–59.
   PubMed Web of Science ®Google Scholar
• Liu, B., Gao, H. M., & Hong, J. S. (2003). Parkinson's disease and exposure to infectious agents and pesticides and the occurrence of brain injury: Role of neuroinflammation. Environmental Health Perspectives, 111, 1065–1073.
   PubMed Web of Science ®Google Scholar
• Luedtke, R. R., Griffin, S. A., Conroy, S. S., Jin, X., Pinto, A., & Sesack, S. R. (1999). Immunoblot and immunohistochemical comparison of murine monoclonal antibodies specific for the rat D1a and D1b dopamine receptor subtypes. Journal of Neuroimmunology, 101, 170–187.
   PubMed Web of Science ®Google Scholar
• Marras, C., & Lang, A. (2008). Invited article: Changing concepts in Parkinson disease. Neurology, 70, 1996–2003.
   PubMed Web of Science ®Google Scholar
• Møller, A., Perrild, H., Pedersen, H., & Høier-Madsen, M. (1989). Parkinson's disease and autoimmunity. Acta Neurologica Scandinavica, 79, 173–175.
   PubMedGoogle Scholar
• Mombaerts, P. (2004). Love at first smell—The 2004 nobel prize in physiology or medicine. New England Journal of Medicine, 351, 2579–2580.
   PubMedGoogle Scholar
• Moscavitch, S. D., Szyper-Kravitz, M., & Shoenfeld, Y. (2009). Autoimmune pathology accounts for common manifestations in a wide range of neuro-psychiatric disorders: The olfactory and immune system interrelationship. Clinical Immunology, 130, 235–243.
   PubMedGoogle Scholar
• Myers, P. R., Donlon, M., McCarthy, K., Livengood, D., & Shain, W. (1976). Evidence for a dopamine receptor antibody. Biochemical and Biophysical Research Communications, 72, 1311–1318.
   PubMedGoogle Scholar
• Neef, D. (2006). Walling AD. Dementia with Lewy bodies: An emerging disease. American Family Physician, 73, 1223–1229.
   PubMed Web of Science ®Google Scholar
• Nussbaum, R. L., & Ellis, C. E. (2003). Alzheimer's disease and Parkinson disease. New England Journal of Medicine, 348, 1356–1364.
   PubMed Web of Science ®Google Scholar
• Orr, C. F., Rowe, D. B., Mizuno, Y., Mori, H., & Halliday, G. M. (2005). A possible role of humoral immunity in the pathogenesis of Parkinson's disease. Brain, 128, 2665–2674.
   PubMed Web of Science ®Google Scholar
• Papachroni, K. K., Ninkina, N., Papapanagiotou, A., Hadjigeorgiou, G. M., Xiromerisiou, G., Papadimitriou, A., (2007). Autoantibodies to alpha-synuclein in inherited Parkinson's disease. Journal of Neurochemistry, 101, 749–756.
   PubMed Web of Science ®Google Scholar
• Plug, M. J., Maassen, J. A., & Moller, W. (1992). An anti-peptide antibody that recognizes the dopamine D2 receptor from bovine striatum. European Journal of Biochemistry, 206, 123–130.
   PubMedGoogle Scholar
• Rolls, E. T. (2005). Taste, olfactory, and food texture processing in the brain, and the control of food intake. Physiology & Behavior, 85, 45–56.
   PubMed Web of Science ®Google Scholar
• Rosner, S., Giladi, N., & Orr-Urtreger, A. (2008). Advances in the genetics of Parkinson's disease. Acta Pharmacologica Sinica, 29, 21–34.
   PubMedGoogle Scholar
• Shoenfeld, N., Agmon-Levin, N., Flitman-Katzevman, I., Paran, D., Katz, B.S., Kivity, S., Langevitz, P., Zandman-Goddard, G., Shoenfeld, Y. (2009). The sense of smell in systemic lupus erythematosus. Arthritis Rheum., 60, 1484–1487.
   PubMed Web of Science ®Google Scholar
• Shoenfeld, Y. (2007). To smell autoimmunity: Anti-P-ribosomal autoantibodies, depression, and the olfactory system. Journal of Autoimmune, 28, 165–169.
   PubMed Web of Science ®Google Scholar
• Shoenfeld, Y., Blank, M., Abu-Shakra, M., Amital, H., Barzilai, O., Berkun, Y., (2008). The mosaic of autoimmunity: Prediction, autoantibodies and therapy in autoimmune disease. IMAJ, 10, 13–19.
   Google Scholar
• Shoenfeld, Y., Gilburd, B., Abu-Shakra, M., Amital, H., Barzilai, O., Berkun, Y., (2008). The mosaic of autoimmunity: Genetic factor involved in autoimmune disease. IMAJ, 10, 3–7.
   Google Scholar
• Shoenfeld, Y., Zandman-Goddard, G., Stojanovich, L., Cutolo, M., Amital, H., Levy, Y., (2008). The mosaic of autoimmunity: Hormonal and environmental factors involved in autoimmune disease. IMAJ, 10, 8–12.
   Google Scholar
• Strous, R. D., & Shoenfeld, Y. (2006a). Schizophrenia, autoimmunity and immune system dysregulation: A comprehensive modal updated and revised. Journal of Autoimmune, 27, 71–80.
   PubMed Web of Science ®Google Scholar
• Strous, R. D., & Shoenfeld, Y. (2006b). To smell the immune system: Olfaction, autoimmunity and brain involvement. Autoimmunity Reviews, 6, 54–60.
   PubMed Web of Science ®Google Scholar
• Toubi, E., & Shoenfeld, Y. (2007). Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmunity Reviews, 6, 119–125.
   PubMed Web of Science ®Google Scholar
• Uitti, R. J., & Calne, D. B. (1993). Pathogenesis of idiopathic parkinsonism. European Neurology, 33, 6–23.
   PubMedGoogle Scholar
• Valldeoriola, F. (1999). Movement disorders of autoimmune origin. Journal of Neurology, 246, 423–431.
   PubMedGoogle Scholar
• Wilson, R. S., Arnold, S. E., Buchman, A. S., Tang, Y., & Bennett, D. A. (2008). Odor identification and progression of parkinsonian signs in older persons. Experimental Aging Research, 34, 173–187.
   PubMed Web of Science ®Google Scholar
• Zandman-Goddard, G., Chapman, J., & Shoenfeld, Y. (2007). Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum, 36, 297–315.
   PubMed Web of Science ®Google Scholar
• Zappia, M., Crescibene, L., Bosco, D., Arabia, G., Nicoletti, G., Bagala, A., (2002). Anti-GM1 ganglioside antibodies in Parkinson's disease. Acta Neurologica Scandinavica, 106, 54–57.
   PubMed Web of Science ®Google Scholar
• Zorzon, M., Ukmar, M., Bragadin, L. M., Zanier, F., Antonello, R. M., & Cazzato, G. (2000). Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: A clinical and MR study. Multiple Sclerosis, 6, 386–390.
   PubMedGoogle Scholar